|
1
|
World Psoriasis Day: International
Federation of Psoriasis Associations.
|
|
2
|
Singh S, Pradhan D, Puri P, Ramesh V,
Aggarwal S, Nayek A and Jain AK: Genomic alterations driving
psoriasis pathogenesis. Gene. 683:61–71. 2019. View Article : Google Scholar
|
|
3
|
Huang YH, Kuo CF, Huang LH and Hsieh MY:
Familial aggregation of psoriasis and co-aggregation of autoimmune
diseases in affected families. J Clin Med. 8:1152019. View Article : Google Scholar :
|
|
4
|
Menter MA, Armstrong AW, Gordon KB and Wu
JJ: Common and not-so-common comorbidities of psoriasis. Semin
Cutan Med Surg. 37:S48–S51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takeshita J, Grewal S, Langan SM, Mehta
NN, Ogdie A, Van Voorhees AS and Gelfand JM: Psoriasis and comorbid
diseases part I. Epidemiology J Am Acad Dermatol. 76:377–390. 2017.
View Article : Google Scholar
|
|
6
|
Choudhary S, Patel R, Pradhan D, Deval R,
Singh H, Thomas G and Jain AK: Psoriasis and cardiovascular
disorders: Association or epiphenomenon? Meta-Analysis of
observational studies. 3 Biotech. 10:1042020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmitt J and Wozel G: The psoriasis area
and severity index is the adequate criterion to define severity in
chronic plaque-type psoriasis. Dermatology. 210:194–199. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boehncke WH and Schön MP: Psoriasis.
Lancet. 386:983–994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. New Engl J Med. 361:496–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bowcock AM, Shannon W, Du F, Duncan J, Cao
K, Aftergut K, Catier J, Fernandez-Vina MA and Menter A: Insights
into psoriasis and other inflammatory diseases from large-scale
gene expression studies. Hum Mol Genet. 10:1793–1805. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oestreicher JL, Walters IB, Kikuchi T,
Gilleaudeau P, Surette J, Schwertschlag U, Dorner AJ, Krueger JG
and Trepicchio WL: Molecular classification of psoriasis
disease-associated genes through pharmacogenomic expression
profiling. Pharmacogenomics J. 1:272–287. 2001. View Article : Google Scholar
|
|
12
|
Zhou X, Krueger JG, Kao MC, Lee E, Du F,
Menter A, Wong WH and Bowcock AM: Novel mechanisms of T-cell and
dendritic cell activation revealed by profiling of psoriasis on the
63,100-element oligonucleotide array. Physiol Genomics. 13:69–78.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kulski JK, Kenworthy W, Bellgard M, Taplin
R, Okamoto K, Oka A, Mabuchi T, Ozawa A, Tamiya G and Inoko H: Gene
expression profiling of Japanese psoriatic skin reveals an
increased activity in molecular stress and immune response signals.
J Mol Med (Berl). 83:964–975. 2005. View Article : Google Scholar
|
|
14
|
Mee JB, Johnson CM, Morar N, Burslem F and
Groves RW: The psoriatic transcriptome closely resembles that
induced by interleukin-1 in cultured keratinocytes. Am J Pathol.
171:32–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao Y, Richman L, Morehouse C, de los
Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener
PA and Jallal B: Type I interferon: Potential therapeutic target
for psoriasis? PLoS One. 3:e27372008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gudjonsson JE, Ding J, Johnston A, Tejasvi
T, Guzman AM, Nair RP, Voorhees JJ, Abecasis GR and Elder JT:
Assessment of the psoriatic transcriptome in a large sample:
Additional regulated genes and comparisons with in vitro models. J
Invest Dermatol. 130:1829–1840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choudhary S, Pradhan D, Khan NS, Singh H,
Thomas G and Jain A: Decoding psoriasis: Integrated bioinformatics
approach to understand hub genes and involved pathways. Curr Pharm
Des. 11:102020.
|
|
18
|
Coda AB, Icen M, Smith JR and Sinha AA:
Global transcriptional analysis of psoriatic skin and blood
confirms known disease-associated pathways and highlights novel
genomic 'hot spots' for differentially expressed genes. Genomics.
100:18–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swindell WR, Johnston A, Voorhees JJ,
Elder JT and Gudjonsson JE: Dissecting the psoriasis transcriptome:
Inflammatory- and cytokine-driven gene expression in lesions from
163 patients. BMC Genomics. 14:5272013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim J, Bissonnette R, Lee J, Correa da
Rosa J, Suárez-Fariñas M, Lowes MA and Krueger JG: The spectrum of
mild to severe psoriasis vulgaris is defined by a common activation
of il-17 pathway genes, but with key differences in immune
regulatory genes. J Invest Dermatol. 136:2173–2182. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-Analysis of affymetrix genechip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun C, Yuan Q, Wu D, Meng X and Wang B:
Identification of core genes and outcome in gastric cancer using
bioinformatics analysis. Oncotarget. 8:70271–70280. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y and Zheng T: Screening of hub genes
and pathways in colorectal cancer with microarray technology.
Pathol Oncol Res. 20:611–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar :
|
|
26
|
Welter D, MacArthur J, Morales J, Burdett
T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L and
Parkinson H: The NHGRI GWAS catalog, a curated resource of
SNP-trait associations. Nucleic Acids Res. 42:D1001–D1006. 2014.
View Article : Google Scholar :
|
|
27
|
Becker KG, Barnes KC, Bright TJ and Wang
SA: The genetic association database. Nat Genet. 36:431–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mattingly CJ, Rosenstein MC, Colby GT,
Forrest JN Jr and Boyer JL: The comparative toxicogenomics database
(CTD): A resource for comparative toxicological studies. J Exp Zool
A Comp Exp Biol. 305:689–692. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Landrum MJ, Lee JM, Riley GR, Jang W,
Rubinstein WS, Church DM and Maglott DR: ClinVar: Public archive of
relation-ships among sequence variation and human phenotype.
Nucleic Acids Res. 42:D980–D985. 2014. View Article : Google Scholar
|
|
30
|
Apweiler R, Bairoch A, Wu CH, Barker WC,
Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, et
al: UniProt: The universal protein knowledgebase. Nucleic Acids
Res. 32:D115–D119. 2004. View Article : Google Scholar :
|
|
31
|
Piñero J, Bravo À, Queralt-Rosinach N,
Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz
F and Furlong LI: DisGeNET: A comprehensive platform integrating
information on human disease-associated genes and variants. Nucleic
Acids Res. 45:D833–D839. 2017. View Article : Google Scholar :
|
|
32
|
Carvalho-Silva D, Pierleoni A, Pignatelli
M, Ong C, Fumis L, Karamanis N, Carmona M, Faulconbridge A,
Hercules A, McAuley E, et al: Open targets platform: New
developments and updates two years on. Nucleic Acids Res.
47:D1056–D1065. 2019. View Article : Google Scholar :
|
|
33
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar
|
|
34
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Y, Zhong Z, Ding Y, Zhang W, Ma Y and
Zhou L: Bioinformatic identification of key genes and pathways that
may be involved in the pathogenesis of HBV-associated acute liver
failure. Genes Dis. 5:349–357. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nayak S, Pradhan D, Singh H and Reddy MS:
Computational screening of potential drug targets for pathogens
causing bacterial pneumonia. Microb Pathog. 130:271–282. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lowes MA, Suárez-Fariñas M and Krueger JG:
Immunology of psoriasis. Annu Rev Immunol. 32:227–255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Campanati A, Goteri G, Simonetti O,
Ganzetti G, Giuliodori K, Stramazzotti D, Morichetti D, Bernardini
ML, Mannello B, Fabris G and Offidani A: CTACK/CCL27 expression in
psoriatic skin and its modification after administration of
etanercept. Br J Dermatol. 157:1155–1160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gudjonsson J, Johnston A, Stoll S, Riblett
MB, Xing X, Kochkodan JJ, Ding J, Nair RP, Aphale A, Voorhees JJ
and Elder JT: Evidence for altered wnt signaling in psoriatic skin.
J Invest Dermatol. 130:1849–1859. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Liu X, Liu N and Chen H:
Prediction of crucial epigenetically-associated, differentially
expressed genes by integrated bioinformatics analysis and the
identification of S100A9 as a novel biomarker in psoriasis. Int J
Mol Med. 45:93–102. 2020.
|
|
41
|
Ogawa E, Sato Y, Minagawa A and Okuyama R:
Pathogenesis of psoriasis and development of treatment. J Dermatol.
45:264–272. 2018. View Article : Google Scholar
|
|
42
|
Chen W, Xie K, Liu X and Chen H:
Identification of key path-ways and genes in psoriasis via gene
microarray analysis. Mol Med Rep. 13:2327–2337. 2016.PubMed/NCBI
|
|
43
|
Tan X, Zhang X, Pan L, Tian X and Dong P:
Identification of key pathways and genes in advanced coronary
atherosclerosis using bioinformatics analysis. Biomed Res Int.
2017:e43234962017. View Article : Google Scholar
|
|
44
|
Elfatoiki FZ, Azhari ME, Kettani AE,
Serhier Z, Othmani MB, Timinouni M, Benchikhi H, Chiheb S and
Fellah H: Psoriasis and staphylococcus aureus skin colonization in
moroccan patients. Pan Afr Med J. 23:332016.PubMed/NCBI
|
|
45
|
Johnston A, Gudjonsson JE, Aphale A,
Guzman AM, Stoll SW and Elder JT: EGFR and IL-1 signaling
synergistically promote keratinocyte antimicrobial defenses in a
differentiation-dependent manner. J Invest Dermatol. 131:329–337.
2011. View Article : Google Scholar :
|
|
46
|
Yoshida A, Kanno H, Watabe D, Akasaka T
and Sawai T: The role of heparin-binding EGF-like growth factor and
amphi-regulin in the epidermal proliferation of psoriasis in
cooperation with TNFalpha. Arch Dermatol Res. 300:37–45. 2008.
View Article : Google Scholar
|
|
47
|
Piepkorn M, Predd H, Underwood R and Cook
P: Proliferation-differentiation relationships in the expression of
heparin-binding epidermal growth factor-related factors and erbB
receptors by normal and psoriatic human keratinocytes. Arch
Dermatol Res. 295:93–101. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhu KJ, Zhang C, Li M, Zhu CY, Shi G and
Fan YM: Leptin levels in patients with psoriasis: A meta-analysis.
Clin Exp Dermatol. 38:478–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Manczinger M and Kemény L: Novel factors
in the pathogenesis of psoriasis and potential drug candidates are
found with systems biology approach. PLoS One. 8:e807512013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Khabour OF, Alomari MA and Abu Obaid AA:
The relation-ship of adiponectin level and ADIPOQ gene variants
with BMI among young adult women. Dermatoendocrinol.
10:e14779022018. View Article : Google Scholar
|
|
51
|
Kyriakou A, Patsatsi A, Sotiriadis D and
Goulis DG: Serum leptin, resistin, and adiponectin concentrations
in psoriasis: A meta-analysis of observational studies.
Dermatology. 233:378–389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Campanati A, Consales V, Orciani M,
Giuliodori K, Ganzetti G, Bobyr I, Sorgentoni G, di Primio R and
Offidani A: Role of mesenchymal stem cells in the pathogenesis of
psoriasis: Current perspectives. Psoriasis (Auckl). 7:73–85.
2017.
|
|
53
|
Ayala-Fontánez N, Soler DC and McCormick
TS: Current knowledge on psoriasis and autoimmune diseases.
Psoriasis (Auckl). 6:7–32. 2016.
|
|
54
|
Suárez-Fariñas M, Li K, Fuentes-Duculan J,
Hayden K, Brodmerkel C and Krueger JG: Expanding the psoriasis
disease profile: Interrogation of the skin and serum of patients
with moderate-to-severe psoriasis. J Invest Dermatol.
132:2552–2564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pietrzak A, Michalak-Stoma A, Chodorowska
G and Szepietowski JC: Lipid disturbances in psoriasis: An update.
Mediators Inflamm. 2010:5356122010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Disteldorf EM, Krebs CF, Paust HJ, Turner
JE, Nouailles G, Tittel A, Meyer-Schwesinger C, Stege G, Brix S,
Velden J, et al: CXCL5 drives neutrophil recruitment in
TH17-mediated GN. J Am Soc Nephrol. 26:55–66. 2015. View Article : Google Scholar :
|
|
57
|
Adhikary T, Wortmann A, Schumann T,
Finkernagel F, Lieber S, Roth K, Toth PM, Diederich WE, Nist A,
Stiewe T, et al: The transcriptional PPARβ/δ network in human
macrophages defines a unique agonist-induced activation state.
Nucleic Acids Res. 43:5033–5051. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gerkowicz A, Socha M, Pietrzak A,
Zubilewicz T and Krasowska D: The role of VEGF in psoriasis: An
update. Acta Angiologica. 24:134–140. 2018. View Article : Google Scholar
|
|
59
|
Xue X, Wu J, Li J, Xu J, Dai H, Tao C, Li
C and Hu J: Indirubin attenuates mouse psoriasis-like skin lesion
in a CD274-dependent manner: An achievement of RNA sequencing.
Biosci Rep. 38:BSR201809582018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Korkmaz S and Korkmaz H: Effect of
alterations in apoptotic pathway on development of metabolic
syndrome in patients with psoriasis vulgaris. Br J Dermatol.
176:1549–1557. 2017. View Article : Google Scholar
|
|
61
|
Zaba LC, Suárez-Fariñas M, Fuentes-Duculan
J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA and Krueger
JG: Effective treatment of psoriasis with etanercept is linked to
suppression of IL-17 signaling, not immediate response TNF genes. J
Allergy Clin Immunol. 124:1022–1010. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li GB, Ma S, Yang LL, Ji S, Fang Z, Zhang
G, Wang LJ, Zhong JM, Xiong Y, Wang JH, et al: Drug discovery
against psoriasis: Identification of a new potent fms-like tyrosine
kinase 3 (FLT3) inhibitor,
1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-
3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, that showed
potent activity in a psoriatic animal model. J Med Chem.
59:8293–8305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Greenberg EN, Marshall ME, Jin S,
Venkatesh S, Dragan M, Tsoi LC, Gudjonsson E, Nie Q, Takahashi JS
and Andersen B: Circadian control of interferon-sensitive gene
expression in murine skin. Proc Natl Acad Sci USA. 117:5761–5771.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhou S, Matsuyoshi N, Takeuchi T, Ohtsuki
Y and Miyachi Y: Reciprocal altered expression of T-cadherin and
P-cadherin in psoriasis vulgaris. Br J Dermatol. 149:268–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chung E, Cook PW, Parkos CA, Park YK,
Pittelkow MR and Coffey RJ: Amphiregulin causes functional
downregulation of adherens junctions in psoriasis. J Invest
Dermatol. 124:1134–1140. 2005. View Article : Google Scholar
|
